BACKGROUND: Traditional assessment and treatment of bipolar disorder (BD) often overlooks an important feature of the illness, mood instability (MI). MI - the presence of intense, rapidly shifting emotional states - is associated with a number of poor prognostic outcomes. This study examined whether MI among adolescents with BD was cross-sectionally related to bipolar subtype (I vs. II) and prognostically associated with symptoms and functioning over 3 months. METHODS: Participants included 145 adolescents (mean age: 15.6 years ± 1.4) with BD I or II with a mood episode in the previous 3 months. Depression and (hypo)mania instability were computed using the root mean square successive difference (rMSSD) score, reflecting both the size and temporal order of changes in weekly depression and (hypo)mania scores (over 12 weeks) from the Adolescent Longitudinal Interval Follow-Up Evaluation. RESULTS: Greater depression instability was associated with BD II, whereas greater (hypo)mania instability was associated with BD I. Baseline MI, particularly depression, predicted more instability, a higher percentage of weeks in a clinical mood state, and poorer global functioning over 3 months, even when covarying concurrent mood severity scores. LIMITATIONS: The clinical measure of symptoms used retrospective reports of clinically significant symptoms only. We were unable to standardize medication use or adherence. CONCLUSIONS: MI differs by diagnostic subtype, is relatively stable over time, and predicts clinical and functional outcomes. Targeting MI should be considered a clinical focus to augment traditional methods of assessing and treating BD during adolescence to enhance clinical and functional outcomes.
BACKGROUND: Traditional assessment and treatment of bipolar disorder (BD) often overlooks an important feature of the illness, mood instability (MI). MI - the presence of intense, rapidly shifting emotional states - is associated with a number of poor prognostic outcomes. This study examined whether MI among adolescents with BD was cross-sectionally related to bipolar subtype (I vs. II) and prognostically associated with symptoms and functioning over 3 months. METHODS:Participants included 145 adolescents (mean age: 15.6 years ± 1.4) with BD I or II with a mood episode in the previous 3 months. Depression and (hypo)mania instability were computed using the root mean square successive difference (rMSSD) score, reflecting both the size and temporal order of changes in weekly depression and (hypo)mania scores (over 12 weeks) from the Adolescent Longitudinal Interval Follow-Up Evaluation. RESULTS: Greater depression instability was associated with BD II, whereas greater (hypo)mania instability was associated with BD I. Baseline MI, particularly depression, predicted more instability, a higher percentage of weeks in a clinical mood state, and poorer global functioning over 3 months, even when covarying concurrent mood severity scores. LIMITATIONS: The clinical measure of symptoms used retrospective reports of clinically significant symptoms only. We were unable to standardize medication use or adherence. CONCLUSIONS: MI differs by diagnostic subtype, is relatively stable over time, and predicts clinical and functional outcomes. Targeting MI should be considered a clinical focus to augment traditional methods of assessing and treating BD during adolescence to enhance clinical and functional outcomes.
Authors: B Geller; K Bolhofner; J L Craney; M Williams; M P DelBello; K Gundersen Journal: J Am Acad Child Adolesc Psychiatry Date: 2000-12 Impact factor: 8.829
Authors: Tina R Goldstein; Wonho Ha; David A Axelson; Benjamin I Goldstein; Fangzi Liao; Mary Kay Gill; Neal D Ryan; Shirley Yen; Jeffrey Hunt; Heather Hower; Martin Keller; Michael Strober; Boris Birmaher Journal: Arch Gen Psychiatry Date: 2012-11
Authors: Boris Birmaher; David Axelson; Benjamin Goldstein; Michael Strober; Mary Kay Gill; Jeffrey Hunt; Patricia Houck; Wonho Ha; Satish Iyengar; Eunice Kim; Shirley Yen; Heather Hower; Christianne Esposito-Smythers; Tina Goldstein; Neal Ryan; Martin Keller Journal: Am J Psychiatry Date: 2009-05-15 Impact factor: 18.112
Authors: Chantal Henry; Donatienne Van den Bulke; Frank Bellivier; Isabelle Roy; Joël Swendsen; Katia M'Baïlara; Larry J Siever; Marion Leboyer Journal: Psychiatry Res Date: 2008-03-04 Impact factor: 3.222
Authors: Boris Birmaher; Benjamin I Goldstein; David A Axelson; Kelly Monk; Mary Beth Hickey; Jieyu Fan; Satish Iyengar; Wonho Ha; Rasim S Diler; Tina Goldstein; David Brent; Cecile D Ladouceur; Dara Sakolsky; David J Kupfer Journal: Bipolar Disord Date: 2013-04-03 Impact factor: 6.744
Authors: Timothy J Trull; Marika B Solhan; Sarah L Tragesser; Seungmin Jahng; Phillip K Wood; Thomas M Piasecki; David Watson Journal: J Abnorm Psychol Date: 2008-08
Authors: Molly Patapoff; Marina Ramsey; Madison Titone; Christopher N Kaufmann; Atul Malhotra; Sonia Ancoli-Israel; David Wing; Ellen Lee; Lisa T Eyler Journal: J Psychiatr Res Date: 2022-04-03 Impact factor: 5.250
Authors: Thomas D Bjella; Margrethe Collier Høegh; Stine Holmstul Olsen; Sofie R Aminoff; Elizabeth Barrett; Torill Ueland; Romain Icick; Ole A Andreassen; Mari Nerhus; Henrik Myhre Ihler; Marthe Hagen; Cecilie Busch-Christensen; Ingrid Melle; Trine Vik Lagerberg Journal: Front Med Technol Date: 2022-07-22
Authors: Maria Faurholt-Jepsen; Mads Frost; Jonas Busk; Ellen Margrethe Christensen; Jakob E Bardram; Maj Vinberg; Lars Vedel Kessing Journal: Int J Bipolar Disord Date: 2019-02-01